APP metabolism is regulated by p97/VCP through an autophagy and endolysosome-dependent mechanism
Figueroa-Garcia, A.; BRISOIRE, L.; BAUD, C.; CAILLIEREZ, R.; EDDARKAOUI, S.; EVRARD, C.; Saliou, J.-M.; BEGARD, S.; COEVOET, M.; ABOUELFARAH, H.; TRICHIES, A.; BUEE, L.; MELNYK, P.; VINGTDEUX, V.; PARDOSSI-PIQUARD, R.; Checler, F.; Sergeant, N.
Show abstract
Deregulation of amyloid precursor protein (APP) metabolism leads to the production of pathological proteoforms of A{beta} peptides, which ultimately form amyloid deposits, a primary pathological feature of Alzheimers disease (AD). The accumulation of misfolded proteins and alterations in protein degradation systems, such as the ubiquitin-proteasome system, endoplasmic reticulum-associated degradation, and autophagy-lysosomal pathways, also contribute to AD development. The Valosin-Containing Protein AAA-ATPase (p97/VCP) is a crucial regulator of proteostasis, facilitating the clearance of misfolded proteins by the proteasome and other protein degradation systems. Here, we investigated whether VCP influences APP processing. Reducing VCP expression or inhibiting its ATPase activity led to the accumulation of mature, full-length APP in cells, thereby decreasing APP trafficking to the cell surface. Downstream of APP-CTFs secretase processing, p97/VCP modulates APP-CTFs cleavage and degradation via autophagy and endolysosomal-dependent mechanisms. Our findings demonstrate that VCP is involved in APP metabolism at two levels: controlling APP trafficking within the cell secretory pathway and regulating autophagy-dependent degradation of APP-CTFs, suggesting a potential role for VCP in the APP deregulation observed in AD.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.